This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Accardo, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Accardo, P.
Related Collections
Right arrow Children with Disabilities
Right arrow Developmental and Behavioral Pediatrics

AAP Grand Rounds 2:51 (1999)
© 1999 American Academy of Pediatrics

CHILDREN WITH DISABILITIES

Stimulant Medications Decrease Risk of Substance Abuse in Children with ADHD

Source: Biederman J, Wilens T, Mick E, et al. Pharmacotherapy of attention deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2). URL:http://www.pediatrics.org/cgi/content/full/104/2/e20.

The first 20% of the full text of this article appears below.

A 4-year longitudinal follow-up study of children (male and older than 15 years of age) with ADHD assessed the association of psychotropic medication and the development of substance use disorder (SUD). Unmedicated subjects with ADHD (N=19) were at a statistically significant increased risk for any SUD at follow up (75%) compared to non-ADHD controls (N=137) who had an SUD incidence of 18% (p< .001). Medicated subjects with ADHD (N=56) were at significantly reduced risk for any SUD . . . [Full Text of this Article]

Pasquale Accardo, MD, FAAP
Department of Pediatrics, New York Medical College, Valhalla, NY